Clinical Trial Update: Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease

View source ↗

Summary

A long-term study assessing the safety and tolerability of Spiolto Respimat in Japanese patients with chronic obstructive pulmonary disease has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spiolto Respimat (tiotropium/olodaterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2019-12-06